• The Benetton family, together with Blackstone, is reportedly close to a takeover bid for Atlantia.
  • Sika sales jump 22% to CHF 2.4bn in Q1, boosted by volumes and price increases.
  • Nokia will stop doing business in Russia.
  • Givaudan reports Q1 sales growth of 4.6%.
  • Honda will invest $64B in R&D over time to strengthen in electric.
  • Shopify launches a ten-for-one stock split.
  • Meta Platforms tests virtual item sales in the metaverse.
  • Bone Therapeutics signs dilutive convertible bond agreement with Alpha Blue Ocean.
  • BB Biotech completes its share repurchase program.
  • ASOS first-half profit drops 87% due to supply chain constraints.
  • Lalique signs a new licensing agreement to create and market fragrances for Superdry.
  • The European Commission has given the green light to Parker-Hannifin's proposed acquisition of the British company Meggitt for £6.3 billion.
  • American Airlines announced Tuesday that it expects revenue to fall 16% in the first three months of the year compared to the first quarter of 2019, which was before the COVID-19 pandemic, as the sector suffered from a lack of headcount in particular.
  • Gilead Sciences - The Food and Drug Administration (FDA) on Monday night lifted an order to halt clinical trials of a treatment for certain forms of blood cancer developed by the company, which was issued in January to review safety data from those trials. Piper Sandler raised its price target after the decision to $72 from $71.
  • Myovant and Pfizer - The U.S. drug agency informed the two U.S. companies that their application to extend the use of Myfembree for endometriosis pain was deficient. 

Main earnings releases: LVMH, Sika, Givaudan, Albertsons, JD Sports, Evotec, Pennon, ASOS ...